H.R. 9594

H.R. 9594: To amend the Federal Food, Drug, and Cosmetic Act to ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics, and for other purposes.

Introduced Debbie Dingell (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9594 aims to amend the Federal Food, Drug, and Cosmetic Act to prohibit the intentional addition of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetics. These substances, often referred to as 'forever chemicals,' are known for their persistence in the environment and potential health risks.

Positive Media Summary

Media coverage has generally praised H.R. 9594 as a necessary step towards protecting public health and the environment. Advocates highlight the importance of reducing harmful chemicals in consumer products, especially cosmetics used by vulnerable populations such as children and pregnant women.

Negative Media Summary

Some critics argue that the bill could impose unnecessary regulations on the cosmetics industry, potentially leading to increased costs for consumers and limiting product availability. Concerns have also been raised about the feasibility of implementing such a ban without affecting the quality and safety of cosmetic products.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$315,000,000
PAC Percentage
0%
Policy Area
Health

The analysis of H.R. 9594, which aims to ban the use of certain harmful substances in cosmetics, reveals no direct industry overlaps between the sponsor Debbie Dingell's top donor industries and the subject matter of the bill. Dingell's primary donor industries include Health Professionals, contributing $240 million, and Retired individuals, contributing $75 million. Since these industries do not have a direct connection to the cosmetics sector or the specific substances addressed in this legislation, the potential for conflicts of interest appears minimal. Voters should be aware that while large donations can raise questions about influence, in this case, the lack of overlap suggests that the bill may be driven more by public health concerns than by donor interests.

Industry Overlap — Follow the Money

These industries are both affected by this bill and among the sponsor's top donors.

Industry Match Type Related Subject Donations
Health Professionals (H01) Sector Health $240,000,000
Total from overlapping industries $240,000,000
Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
AVIS BUDGET GROUP, INC. AVIS BUDGET GROUP, INC. $240,000
NISSAN NORTH AMERICA, INC. SQUIRE PATTON BOGGS $80,000
IAC SQUIRE PATTON BOGGS $60,000
BALANCE OF NATURE AMERICAN CAPITOL GROUP $45,000
SONOVA USA. INC. AMERICAN CAPITOL GROUP $30,000
THE MCKEON GROUP INC. (ON BEHALF OF D-WAVE GOVERNMENT INC.) PLURUS STRATEGIES, LLC $30,000
GLOBAL ARM PLURUS STRATEGIES, LLC $30,000
SOCIETY OF GENERAL INTERNAL MEDICINE CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $30,000
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE PLURUS STRATEGIES, LLC $20,000
THE BENNETT GROUP DC ON BEHALF OF ENEXOR BIOENERGY AMERICAN CAPITOL GROUP $10,000
THE CORMAC GROUP, ON BEHALF OF TENDO AMERICAN CAPITOL GROUP undisclosed
AMERICAN PETROLEUM INSTITUTE (API) KELLER AND HECKMAN, LLP undisclosed
LASSEN PEAK, INC. SQUIRE PATTON BOGGS undisclosed
'INTERNET OF EVERYTHING CORP. (FKA QUISNET). AMERICAN CAPITOL GROUP undisclosed
HYUNDAI MOTOR COMPANY, FORMERLY REPORTED AS KIA CORPORATION SQUIRE PATTON BOGGS undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Debbie Dingell, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us